BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11298618)

  • 1. Prognostic factors and survival after hepatic resection for hepatocellular carcinoma without cirrhosis.
    Nagasue N; Ono T; Yamanoi A; Kohno H; El-Assal ON; Taniura H; Uchida M
    Br J Surg; 2001 Apr; 88(4):515-22. PubMed ID: 11298618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anatomical resection of hepatocellular carcinoma: A critical review of the procedure and its benefits on survival.
    Kang KJ; Ahn KS
    World J Gastroenterol; 2017 Feb; 23(7):1139-1146. PubMed ID: 28275294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiparametric assessment of microvascular invasion in hepatocellular carcinoma using gadoxetic acid-enhanced MRI.
    Fujita N; Ushijima Y; Ishimatsu K; Okamoto D; Wada N; Takao S; Murayama R; Itoyama M; Harada N; Maehara J; Oda Y; Ishigami K; Nishie A
    Abdom Radiol (NY); 2024 May; 49(5):1467-1478. PubMed ID: 38360959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of liver resection and living donor liver transplantation in patients with hepatocellular carcinoma within Milan criteria and well-preserved liver function.
    Karakas S; Yilmaz S; Ince V; Akbulut S; Dalda Y; Akatli AN; Kahraman AS; Kutlu R; Carr BI
    Hepatol Forum; 2023 Mar; 4(2):47-52. PubMed ID: 37250925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostication algorithm for non-cirrhotic non-B non-C hepatocellular carcinoma-a multicenter study under the aegis of the French Association of Hepato-Biliary Surgery and liver Transplantation.
    Maulat C; Truant S; Hobeika C; Barbier L; Herrero A; Doussot A; Gagnière J; Girard É; Tranchart H; Regimbeau JM; Fuks D; Cauchy F; Prodeau M; Notte A; Toubert C; Salamé E; El Amrani M; Andrieu S; Muscari F; Shourick J; Suc B
    Hepatobiliary Surg Nutr; 2023 Apr; 12(2):192-204. PubMed ID: 37124677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome after Resection for Hepatocellular Carcinoma in Noncirrhotic Liver-A Single Centre Study.
    Penzkofer L; Mittler J; Heinrich S; Wachter N; Straub BK; Kloeckner R; Stoehr F; Gairing SJ; Bartsch F; Lang H
    J Clin Med; 2022 Sep; 11(19):. PubMed ID: 36233670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A nomogram for predicting the risk of postoperative recurrence of hepatitis B virus-related hepatocellular carcinoma in patients with high preoperative serum glutamyl transpeptidase.
    Zhang JS; Wang ZH; Guo XG; Zhang J; Ni JS
    J Gastrointest Oncol; 2022 Feb; 13(1):298-310. PubMed ID: 35284131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-center experience on actual mid-term (≥5 years) and long-term (≥10 years) survival outcome in patients with hepatocellular carcinoma after curative hepatectomy: A bimodal distribution.
    Fung AKY; Cheng NMY; Chong CCN; Lee KF; Wong J; Cheung SYS; Lok HT; Lai PBS; Ng KKC
    Medicine (Baltimore); 2020 Nov; 99(48):e23358. PubMed ID: 33235106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined preoperative albumin-bilirubin (ALBI) and serum γ-glutamyl transpeptidase (GGT) predicts the outcome of hepatocellular carcinoma patients following hepatic resection.
    Zhang CH; Ni XC; Chen BY; Qiu SJ; Zhu YM; Luo M
    J Cancer; 2019; 10(20):4836-4845. PubMed ID: 31598154
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment strategies for locally advanced hepatocellular carcinoma.
    Fernandes ESM; Rodrigues PD; Álvares-da-Silva MR; Scaffaro LA; Farenzena M; Teixeira UF; Waechter FL
    Transl Gastroenterol Hepatol; 2019; 4():12. PubMed ID: 30976715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative Albumin-Bilirubin Score for Postoperative Solitary Hepatocellular Carcinoma within the Milan Criteria and Child-Pugh A Cirrhosis.
    Dong ZR; Zou J; Sun D; Shi GM; Ke AW; Cai JB; Sun HC; Qiu SJ; Li T; Zhou J; Zhi XT; Fan J
    J Cancer; 2017; 8(18):3862-3867. PubMed ID: 29151974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary administration of Nexrutine inhibits rat liver tumorigenesis and induces apoptotic cell death in human hepatocellular carcinoma cells.
    Alam S; Yadav RS; Pal A; Purshottam SK; Chaudhari BP; Das M; Ansari KM
    Toxicol Rep; 2015; 2():1-11. PubMed ID: 28962332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of surgical margin in patients with hepatocellular carcinoma: A meta-analysis.
    Zhong FP; Zhang YJ; Liu Y; Zou SB
    Medicine (Baltimore); 2017 Sep; 96(37):e8043. PubMed ID: 28906395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical significance of preoperative serum cholesterol and high-density lipoprotein-cholesterol levels in hepatocellular carcinoma.
    Jiang SS; Weng DS; Jiang L; Zhang YJ; Pan K; Pan QZ; Chen CL; Zhao JJ; Zhang XF; Zhang HX; Tang Y; Zhou ZQ; Chen MS; Xia JC
    J Cancer; 2016; 7(6):626-32. PubMed ID: 27076843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term survival after resection of hepatocellular carcinoma.
    Kim KH; Choi YK
    Korean J Hepatobiliary Pancreat Surg; 2012 Aug; 16(3):98-104. PubMed ID: 26388916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AROS Is a Significant Biomarker for Tumor Aggressiveness in Non-cirrhotic Hepatocellular Carcinoma.
    Kwon JH; Ahn KS; Moon YH; Park JY; Wang HJ; Choi KY; Kim G; Joh JW; Lee KG; Kang KJ
    J Korean Med Sci; 2015 Sep; 30(9):1253-9. PubMed ID: 26339164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Levels of Gamma-Glutamyl Transferase and Indocyanine Green Retention Rate at 15 min as Preoperative Predictors of Tumor Recurrence in Patients With Hepatocellular Carcinoma.
    Song P; Inagaki Y; Wang Z; Hasegawa K; Sakamoto Y; Arita J; Tang W; Kokudo N
    Medicine (Baltimore); 2015 May; 94(21):e810. PubMed ID: 26020384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appropriate treatment strategies improve survival of hepatocellular carcinoma patients with portal vein tumor thrombus.
    Ye JZ; Zhang YQ; Ye HH; Bai T; Ma L; Xiang BD; Li LQ
    World J Gastroenterol; 2014 Dec; 20(45):17141-7. PubMed ID: 25493028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of prognostic factors on recurrence after curative resections for hepatocellular carcinoma.
    Han JH; Kim DG; Na GH; Kim EY; Lee SH; Hong TH; You YK
    World J Gastroenterol; 2014 Dec; 20(45):17132-40. PubMed ID: 25493027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transarterial (chemo)embolization for curative resection of hepatocellular carcinoma: a systematic review and meta-analyses.
    Cheng X; Sun P; Hu QG; Song ZF; Xiong J; Zheng QC
    J Cancer Res Clin Oncol; 2014 Jul; 140(7):1159-70. PubMed ID: 24752339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.